Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
The use of menopausal hormone therapy (MHT) has declined due to concerns about its potential side effects. However, its pivotal role in managing postmenopausal osteoporosis is gaining increased recognition. In this article, we explore how MHT assists postmenopausal women in maintaining bone health a...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2023-12-01
|
| Series: | Open Life Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/biol-2022-0759 |
| _version_ | 1797387343101952000 |
|---|---|
| author | Na Zhao Wei Wei Xu Yingfang Li Dong Yin Beili Gu Weiqun |
| author_facet | Na Zhao Wei Wei Xu Yingfang Li Dong Yin Beili Gu Weiqun |
| author_sort | Na Zhao |
| collection | DOAJ |
| description | The use of menopausal hormone therapy (MHT) has declined due to concerns about its potential side effects. However, its pivotal role in managing postmenopausal osteoporosis is gaining increased recognition. In this article, we explore how MHT assists postmenopausal women in maintaining bone health and preventing fractures. Recent research indicates that MHT significantly reduces the risk of fractures in women. This benefit is evident regardless of a woman’s bone mineral density or their use of progestogens. However, there is limited evidence suggesting that the skeletal benefits continue once the treatment is discontinued. Possible complications of MHT include heart attacks, clots, strokes, dementia, and breast cancer. The most suitable candidates for MHT are women who have recently entered menopause, are experiencing menopausal symptoms, and are below 60 years of age with a minimal baseline risk of adverse events. The treatment is available to those who meet these criteria. For women undergoing premature menopause, MHT can be considered as a means to protect bone health, especially if initiated before menopause or if accelerated bone loss is documented soon after menopause. Such decisions should be made after evaluating individual risk factors and benefits. |
| first_indexed | 2024-03-08T22:22:49Z |
| format | Article |
| id | doaj.art-a1944f58eaef43578ebbdbf3b471ea4d |
| institution | Directory Open Access Journal |
| issn | 2391-5412 |
| language | English |
| last_indexed | 2024-03-08T22:22:49Z |
| publishDate | 2023-12-01 |
| publisher | De Gruyter |
| record_format | Article |
| series | Open Life Sciences |
| spelling | doaj.art-a1944f58eaef43578ebbdbf3b471ea4d2023-12-18T12:42:46ZengDe GruyterOpen Life Sciences2391-54122023-12-0118134410.1515/biol-2022-0759Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosisNa Zhao0Wei Wei1Xu Yingfang2Li Dong3Yin Beili4Gu Weiqun5Department of Gynecology, Changshu Hospital Affiliated to Nanjing University of Chinese Medicine, Changshu, 215500, ChinaDepartment of Orthopaedics, Changshu Hospital Affiliated to Soochow University, First People’s Hospital of Changshu City, Changshu, 215500, ChinaDepartment of Gynecology, Changshu Hospital Affiliated to Nanjing University of Chinese Medicine, Changshu, 215500, ChinaDepartment of Obstetrics and Gynecology, Changzhou Geriatric Hospital Affiliated to Soochow University, Changzhou No. 7 People’s Hospital, Changzhou, 213000, ChinaDepartment of Gynecology, Changshu Hospital Affiliated to Nanjing University of Chinese Medicine, Changshu, 215500, ChinaDepartment of Gynecology, Changshu Hospital Affiliated to Nanjing University of Chinese Medicine, Changshu, 215500, ChinaThe use of menopausal hormone therapy (MHT) has declined due to concerns about its potential side effects. However, its pivotal role in managing postmenopausal osteoporosis is gaining increased recognition. In this article, we explore how MHT assists postmenopausal women in maintaining bone health and preventing fractures. Recent research indicates that MHT significantly reduces the risk of fractures in women. This benefit is evident regardless of a woman’s bone mineral density or their use of progestogens. However, there is limited evidence suggesting that the skeletal benefits continue once the treatment is discontinued. Possible complications of MHT include heart attacks, clots, strokes, dementia, and breast cancer. The most suitable candidates for MHT are women who have recently entered menopause, are experiencing menopausal symptoms, and are below 60 years of age with a minimal baseline risk of adverse events. The treatment is available to those who meet these criteria. For women undergoing premature menopause, MHT can be considered as a means to protect bone health, especially if initiated before menopause or if accelerated bone loss is documented soon after menopause. Such decisions should be made after evaluating individual risk factors and benefits.https://doi.org/10.1515/biol-2022-0759osteoporosismenopausal hormone therapybone healthpostmenopause |
| spellingShingle | Na Zhao Wei Wei Xu Yingfang Li Dong Yin Beili Gu Weiqun Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis Open Life Sciences osteoporosis menopausal hormone therapy bone health postmenopause |
| title | Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis |
| title_full | Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis |
| title_fullStr | Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis |
| title_full_unstemmed | Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis |
| title_short | Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis |
| title_sort | role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis |
| topic | osteoporosis menopausal hormone therapy bone health postmenopause |
| url | https://doi.org/10.1515/biol-2022-0759 |
| work_keys_str_mv | AT nazhao roleofmenopausalhormonetherapyinthepreventionofpostmenopausalosteoporosis AT weiwei roleofmenopausalhormonetherapyinthepreventionofpostmenopausalosteoporosis AT xuyingfang roleofmenopausalhormonetherapyinthepreventionofpostmenopausalosteoporosis AT lidong roleofmenopausalhormonetherapyinthepreventionofpostmenopausalosteoporosis AT yinbeili roleofmenopausalhormonetherapyinthepreventionofpostmenopausalosteoporosis AT guweiqun roleofmenopausalhormonetherapyinthepreventionofpostmenopausalosteoporosis |